stockrowHarmony Biosciences Holdings, Inc. (HRMY) vs Mesoblast Limited (MESO)
- Harmony Biosciences Holdings, Inc. HRMY 33.04 +1.76%
- Mesoblast Limited MESO 14.23 +0.92%
Harmony Biosciences Holdings, Inc. and Mesoblast Limited are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and Mesoblast Limited are of similar size ($1.9B and $1.8B). Mesoblast Limited has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 10.7×. Harmony Biosciences Holdings, Inc. grew revenue faster over the last twelve months: 19.8% against −26.5%. Harmony Biosciences Holdings, Inc. has the higher net margin (18.1% vs −1,091.7%) and the higher return on invested capital (30.5% vs 0.00%). Across the 18 metrics below, Harmony Biosciences Holdings, Inc. leads on 16 and Mesoblast Limited on 2.
Valuation
Profitability
| Metric | HRMY | MESO | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.03% | (269.72%) | 68.51% |
| Operating margin | 22.17% | (826.28%) | 0.00% |
| Net margin | 18.05% | (1,091.71%) | 0.00% |
| Free cash flow margin | 32.65% | 0.00% | 0.00% |
| Return on equity | 18.73% | 0.00% | (51.96%) |
| Return on assets | 13.30% | 0.00% | (46.06%) |
| Return on invested capital | 30.45% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack